Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 7.61 0.26% 0.02
INSY closed up 0.26 percent on Friday, October 20, 2017, on 73 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Nov 2

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical INSY trend table...

Date Alert Name Type % Chg
Oct 20 Narrow Range Bar Range Contraction 0.00%
Oct 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Oct 19 NR7 Range Contraction 0.26%
Oct 19 NR7-2 Range Contraction 0.26%
Oct 19 Narrow Range Bar Range Contraction 0.26%

Older signals for INSY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.06
52 Week Low 7.27
Average Volume 579,450
200-Day Moving Average 10.7482
50-Day Moving Average 8.9301
20-Day Moving Average 8.4478
10-Day Moving Average 7.772
Average True Range 0.4137
ADX 29.34
+DI 14.16
-DI 26.94
Chandelier Exit (Long, 3 ATRs ) 9.0689
Chandelier Exit (Short, 3 ATRs ) 8.5111
Upper Bollinger Band 9.9779
Lower Bollinger Band 6.9177
Percent B (%b) 0.23
BandWidth 36.224816
MACD Line -0.4845
MACD Signal Line -0.4031
MACD Histogram -0.0813
Fundamentals Value
Market Cap 553.22 Million
Num Shares 72.7 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -34.59
Price-to-Sales 3.46
Price-to-Book 2.49
PEG Ratio -1.12
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.88
Resistance 3 (R3) 7.89 7.81 7.84
Resistance 2 (R2) 7.81 7.74 7.81 7.82
Resistance 1 (R1) 7.71 7.70 7.70 7.70 7.80
Pivot Point 7.63 7.63 7.63 7.63 7.63
Support 1 (S1) 7.53 7.56 7.52 7.52 7.42
Support 2 (S2) 7.45 7.52 7.45 7.40
Support 3 (S3) 7.35 7.45 7.39
Support 4 (S4) 7.34